Abstract:ABSTRACT Tuberculous meningitis (TBM) is a severe infectious disease affecting the central nervous system, causing high mortality and disability. However, current diagnostic methods for TBM using cerebrospinal fluid (CSF) lack sensitivity and predictive biomarkers for prognosis. We conducted a study on cytokine profiles in CSF and serum samples from TBM patients to identify disease-specific biomarkers. Patients were categorized into three groups: TBM ( n = 17), cryptococcal meningitis ( n = 10), and non-infection ( n = 6), and cytokine levels were quantified using a 48-plex panel. After treatment, we observed a significant reduction in the levels of 12 cytokines, indicating their potential use as biomarkers for treatment monitoring. Among them, monokine induced by interferon-γ (MIG) and interleukin-18 showed significant differences in serum or CSF cytokine levels compared to the control groups. CSF levels of MIG in TBM patients were negatively correlated with the CSF/blood glucose ratio ( r = −0.4728, P = 0.0475). Positive correlations were found between CSF leukocyte counts and several cytokines, including fibroblast growth factor-basic, granulocyte colony-stimulating factor (G-CSF), monocyte chemotactic protein-3, macrophage inflammatory protein 1 alpha (MIP-1α), and tumor necrosis factor alpha. G-CSF and MIP-1α were also positively correlated with CSF protein levels. Receiver operating characteristic curve analysis revealed that MIG exhibited the highest area under the curve of 0.92 [95% confidence interval (CI) 0.82–1.00] with a sensitivity of 0.85 (95% CI 0.58–0.97) and a specificity of 0.87 (95% CI 0.62–0.98), making it a promising diagnostic biomarker for TBM. Our study provides valuable insights into TBM’s pathogenesis and identifies potential biomarkers for diagnosis and evaluating treatment monitoring. IMPORTANCE Tuberculous meningitis is a life-threatening infection with high mortality and disability rates. Current diagnostic methods using cerebrospinal fluid (CSF) samples have limited sensitivity and lack predictive biomarkers for evaluating prognosis. This study’s findings reveal excessive activation of the immune response during tuberculous meningitis (TBM) infection. Notably, a strong negative correlation was observed between CSF levels of monokine induced by interferon-γ (MIG) and the CSF/blood glucose ratio in TBM patients. MIG also exhibited the highest area under the curve with high sensitivity and specificity. This study suggests that MIG may serve as a novel biomarker for differentiating TBM infection in CSF or serum, potentially leading to improved diagnostic accuracy and better patient outcomes.

[Differential Diagnosis in Patients with Tuberculous Meningitis and Cryptococcal Meningitis].

Unique Clinical Features of Cryptococcal Meningitis among Chinese Patients Without Predisposing Diseases Against Patients with Predisposing Diseases

Comparison of cli nical chara cteristics bet ween cryptococcus neoformans meningitis and tuberculous meningitis

Sensitivity and specificity of immunocytochemical staining of mycobacterial antigens in the cytoplasm of cerebrospinal fluid macrophages for diagnosing tuberculous meningitis.

Clinical features and abnormal cerebrospinal fluid findings in patients with central nervous system infections

Clinical Analysis of 38 Cases of Cryptococcus Meningitis

Clinical and Laboratory Factors in the Differential Diagnosis of Tuberculous and Cryptococcal Meningitis in Adult HIV-negative Patients.

The application value of cerebrospinal fluid immunoglobulin in tuberculous meningitis

[An Analysis of the Early Diagnostic Criteria for Tuberculosis Meningitis].

Identification of protein biomarkers in host cerebrospinal fluid for differential diagnosis of tuberculous meningitis and other meningitis

Differences In Cytokine And Chemokine Profiles In Cerebrospinal Fluid Caused By The Etiology Of Cryptococcal Meningitis And Tuberculous Meningitis In Hiv Patients

Diagnostic Model for Discrimination Between Tuberculous Meningitis and Bacterial Meningitis

Clinical analysis of cryptococcal meningitis:21 cases

[Clinical Characteristics for Connective Tissue Disease Complicated with Cryptococcal Meningitis].

Clinical Analysis of Two Cases of Tuberculous Meningocephalitis Combined with Tuberculous Myelitis

Systemic and cerebrospinal fluid biomarkers for tuberculous meningitis identification and treatment monitoring

Value of Clinical and Laboratory Features in Diagnosis of Adult Tuberculous Meningitis

The diagnostic utility of the "Thwaites' system" and "lancet consensus scoring system" in tuberculous vs. non-tuberculous subacute and chronic meningitis: multicenter analysis of 395 adult patients

Validation of Thwaites' Diagnostic Scoring System for the Differential Diagnosis of Tuberculous Meningitis and Bacterial Meningitis.

Clinical analysis of 65 cases of tuberculosis meningitis with fever as primary symptom

Clinical Characteristics and Prognosis of Human Immunodeficiency Virus Infected Patients with Tuberculous Meningitis